Inflammatory and microenvironmental factors involved in breast cancer progression

Archives of Pharmacal Research

Volumn 36, Issue 12, 2013, Pages 1419-1431

  Ham, Mina ^a   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Breast cancer; Inflammation; Invasion; Microenvironment

Indexed keywords

ANGIOPOIETIN 2; C REACTIVE PROTEIN; CYCLOOXYGENASE 2 INHIBITOR; GELATINASE A; MATRIX METALLOPROTEINASE; SPHINGOSINE 1 PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; VASCULOTROPIN;

BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; BREAST CARCINOMA; BREAST METASTASIS; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FIBROBLAST; HUMAN; INFLAMMATORY BREAST CANCER; INTRADUCTAL CARCINOMA; LEUKOCYTE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; METASTASIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT;

ANIMALS; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; TUMOR MICROENVIRONMENT;

EID: 84890859058     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0271-7     Document Type: Review

References (200)

1. Agarwal, S., G.V. Reddy, and P. Reddanna. 2009. Eicosanoids in inflammation and cancer: The role of COX-2. Expert Review of Clinical Immunology 5: 145-165.
2. Ahmed, O.I., A.M. Adel, D.R. Diab, and N.S. Gobran. 2006. Prognostic value of serum level of interleukin-6 and interleukin-8 in metastatic breast cancer patients. Egyptian Journal of Immunology 13: 61-68.
3. Ala-Aho, R., N. Johansson, A.H. Baker, and V.M. Kähäri. 2002. Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells. International Journal of Cancer 97: 283-289. (Pubitemid 34049017)
4. Alemany, R., C.J. van Koppen, K. Danneberg, M. Ter Braak, Zu Meyer, and D. Heringdorf. 2007. Regulation and functional roles of sphingosine kinases. Naunyn Schmiedeberg's Archives of Pharmacology 374: 413-428. (Pubitemid 46215289)
5. Allavena, P., A. Sica, G. Solinas, C. Porta, and A. Mantovani. 2008. The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages. Critical Reviews in Oncology Hematology 66: 1-9. (Pubitemid 351324128)
6. Allin, K.H., B.G. Nordestgaard, H. Flyger, and S.E. Bojesen. 2011. Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: A cohort study. Breast Cancer Research 13: R55.
7. Alpaugh, M.L., J.S. Tomlinson, Z.M. Shao, and S.H. Barsky. 1999. A novel human xenograft model of inflammatory breast cancer. Cancer Research 59: 5079-5084. (Pubitemid 29503962)
8. Ammit, A.J., A.T. Hastie, L.C. Edsall, R.K. Hoffman, Y. Amrani, V.P. Krymskaya, S.A. Kane, S.P. Peters, R.B. Penn, S. Spiegel, and R.A. Panettieri Jr. 2001. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB Journal 15: 1212-1214.
9. Bachelot, T., I. Ray-Coquard, C. Menetrier-Caux, M. Rastkha, A. Duc, and J.Y. Blay. 2003. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. British Journal of Cancer 88: 1721-1726. (Pubitemid 36760416)
10. Baglole, C.J., D.M. Ray, S.H. Bernstein, S.E. Feldon, T.J. Smith, P.J. Sime, and R.P. Phipps. 2006. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunological Investigations 35: 297-325. (Pubitemid 44266778)
11. Balkwill, F., K.A. Charles, and A. Mantovani. 2005. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211-217. (Pubitemid 40568680)
12. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: Back to Virchow? Lancet 357: 539-545. (Pubitemid 32173595)
13. Bartsch, H., and J. Nair. 2006. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: Role of lipid peroxidation, DNA damage, and repair. Langenbeck's Archives of Surgery 391: 499-510. (Pubitemid 44337612)
14. Ben-Baruch, A. 2003. Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: Reciprocal tumor-microenvironment interactions. Breast Cancer Research 5: 31-36. (Pubitemid 36553576)
15. Bertucci, F., P. Finetti, D. Birnbaum, and P. Viens. 2010. Gene expression profiling of inflammatory breast cancer. Cancer 116: 2783-2793.
16. Björklund, M., and E. Koivunen. 2005. Gelatinase-mediated migration and invasion of cancer cells. Biochimica et Biophysica Acta 1755: 37-69. (Pubitemid 40720240)
17. Blann, A.D., G.J. Byrne, and A.D. Baildam. 2002. Increased soluble intercellular adhesion molecule-1, breast cancer and the acute phase response. Blood Coagulation and Fibrinolysis 13: 165-168. (Pubitemid 35001680)
18. Boland, G.P., I.S. Butt, R. Prasad, W.F. Knox, and N.J. Bundred. 2004. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. British Journal of Cancer 90: 423-429. (Pubitemid 38250640)
19. Brasky, T.M., M.R. Bonner, K.B. Moysich, C.B. Ambrosone, J. Nie, M.H. Tao, S.B. Edge, B.V. Kallakury, C. Marian, D.S. Goerlitz, M. Trevisan, P.G. Shields, and J.L. Freudenheim. 2011. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: Differences by molecular subtype. Cancer Causes and Control 22: 965-975.
20. Bronte, V., S. Cingarlini, I. Marigo, C. De Santo, G. Gallina, L. Dolcetti, S. Ugel, E. Peranzoni, S. Mandruzzato, and P. Zanovello. 2006. Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: A novel target for therapeutic intervention. Immunological Investigations 35: 327-357. (Pubitemid 44266779)
21. Candido, J., and T. Hagemann. 2013. Cancer-related inflammation. Journal of Clinical Immunology 33: S79-S84.
22. Cha, Y., Y. Kang, and A. Moon. 2012. HER2 induces expression of leptin in human breast epithelial cells. BMB Report 45: 719-723.
23. Chakrabarti, S., and K.D. Patel. 2005. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Experimental Lung Research 31: 599-621. (Pubitemid 40967244)
24. Chalfant, C.E., and S. Spiegel. 2005. Sphingosine 1-phosphate and ceramide 1-phosphate: Expanding roles in cell signaling. Journal of Cell Science 118: 4605-4612. (Pubitemid 41646371)
25. Chang, S., S.L. Parker, T. Pham, A.U. Buzdar, and S.D. Hursting. 1998. Inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Cancer 82: 2366-2372. (Pubitemid 28283443)
26. Chen, L.Y., G. Woszczek, S. Nagineni, C. Logun, and J.H. Shelhamer. 2008. Cytosolic phospholipase A2a activation induced by S1P is mediated by the S1P3 receptor in lung epithelial cells. American Journal of Physiology Lung Cellular and Molecular Physiology 295: L326-L335.
27. Cole, S.W. 2009. Chronic inflammation and breast cancer recurrence. Journal of Clinical Oncology 27: 3418-3419.
28. Costa, C., R. Soares, J.S. Reis-Filho, D. Leitao, I. Amendoeira, and F.C. Schmitt. 2002. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. Journal of Clinical Pathology 55: 429-434. (Pubitemid 34620779)
29. Coussens, L.M., and Z. Werb. 2002. Inflammation and cancer. Nature 420: 860-867. (Pubitemid 36019639)
30. Cox, J.H., R.A. Dean, C.R. Roberts, and C.M. Overal. 2008. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding. The Journal of Biological Chemistry 283: 19389-19399.
31. Cretu, A., and P.C. Brooks. 2007. Impact of the non-cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunities. Journal of Cellular Physiology 213: 391-402. (Pubitemid 47509718)
32. Crowther, M., N.J. Brown, E.T. Bishop, and C.E. Lewis. 2001. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. Journal of Leukocyte Biology 70: 478-490. (Pubitemid 32954759)
33. Crumley, A.B., D.C. McMillan, M. McKernan, J.J. Going, C.J. Shearer, and R.C. Stuart. 2006. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. British Journal of Cancer 94: 1568-1571. (Pubitemid 43924914)
34. Davies, G., J. Salter, M. Hills, L.A. Martin, N. Sacks, and M. Dowsett. 2003. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clinical Cancer Research 9: 2651-2656. (Pubitemid 36842109)
35. DeNardo, D.G., and L.M. Coussens. 2007. Inflammation and breast cancer: Balancing immune response - Crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Research 9: 212.
36. Denkert, C., K.J. Winzer, B.M. Muller, W. Weichert, S. Pest, M. Kobel, G. Kristiansen, A. Reles, A. Siegert, H. Guski, and S. Hauptmann. 2003. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer 97: 2978-2987. (Pubitemid 36676251)
37. de Visser, K.E., A. Eichten, and L.M. Coussens. 2006. Paradoxical roles of the immune system during cancer development. Nature Reviews Cancer 6: 24-37. (Pubitemid 43053650)
38. Dolezalova, H., G. Shankar, M.C. Huang, D.D. Bikle, and E.J. Goetzl. 2003. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate. Journal of Cellular Biochemistry 88: 732-743. (Pubitemid 36258823)
39. Doronzo, G., I. Russo, L. Mattiello, M. Trovati, and G. Anfossi. 2005. CRP increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Journal of Laboratory and Clinical Medicine 146: 287-298. (Pubitemid 41464406)
40. Du Clos, T.W. 2000. Function of C-reactive protein. Annals of Medicine 32: 274-278. (Pubitemid 30311864)
41. Duffy, M.J., T.M. Maguire, A. Hill, E. McDermott, and N. O'Higgins. 2000. Metalloproteinases: Role in breast carcinogenesis, invasion and metastasis. Breast Cancer Research 2: 252-257. (Pubitemid 32223594)
42. Dupuy, A.M., N. Terrier, L. Sénécal, M. Morena, H. Leray, B. Canaud, J.P. Cristol. 2003. Is C-reactive protein a marker of inflammation? Nephrologie 24: 337-341.
43. Edge, S.B., D.R. Byrd, C.C. Compton, et al. (eds.). 2010. AJCC cancer staging manual, 7th ed, 347-376. New York: Springer.
44. Edsparr, K., P.H. Basse, R.H. Goldfarb, and P. Albertsson. 2011. Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation. Cancer Microenvironment 4: 351-360.
45. Eiró, N., and F.J. Vizoso. 2012. Inflammation and cancer. The World Journal of Gastrointestinal Surgery 4: 62-72.
46. Falconer, J.S., K.C. Fearon, J.A. Ross, R. Elton, S.J. Wigmore, O.J. Garden, and D.C. Carter. 1995. Acute phase protein response and survival duration of patients with pancreatic cancer. Cancer 75: 2077-2082.
47. Fan, S.Q., Q.Y. Wei, M.R. Li, L.Q. Zhang, and Q.C. Liang. 2003. Expression and clinical significance of MMP-2, MMP-9, TIMP-1, and TIMP-2 in breast carcinoma. Ai Zheng 22: 968-973.
48. Federico, A., F. Morgillo, C. Tuccillo, F. Ciardiello, and C. Loguercio. 2007. Chronic inflammation and oxidative stress in human carcinogenesis. International Journal of Cancer 121: 2381-2386. (Pubitemid 350022406)
49. Fisher, K.E., A. Pop, W. Koh, N.J. Anthis, W.B. Saunders, and G.E. Davis. 2006. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G protein and membrane-type matrix metalloproteinase-1-dependent signaling. Molecular Cancer 5: 1-23.
50. Gallager, H.S., and J.E. Martin. 1970. An orientation to the concept of minimal breast cancer. Cancer 28: 1505-1507.
51. Ganter, U., R. Arcone, C. Toniatti, G. Morrone, and G. Ciliberto. 1989. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO Journal 8: 3773-3779. (Pubitemid 20016058)
52. Goldberg, J.E., and K.L. Schwertfeger. 2010. Proinflammatory cytokines in breast cancer: Mechanisms of action and potential targets for therapeutics. Current Drug Targets 11: 1133-1146.
53. Gong, Y., E. Hart, A. Shchurin, and J. Hoover-Plow. 2008. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. The Journal of Clinical Investigation 118: 3012-3024.
54. Greene, E.R., S. Huang, C.N. Serhan, and D. Panigrahy. 2011. Regulation of inflammation in cancer by eicosanoids. Prostaglandins and Other Lipid Mediators 96: 27-36.
55. Hait, N.C., C.A. Oskeritzian, S.W. Paugh, S. Milstien, and S. Spiegel. 2006. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochimica et Biophysica Acta 1758: 2016-2026. (Pubitemid 44879368)
56. Han, Y., F. Mao, Y. Wu, X. Fu, X. Zhu, S. Zhou, W. Zhang, Q. Sun, and Y. Zhao. 2011. Prognostic role of C-reactive protein in breast cancer: A systematic review and meta-analysis. The International Journal of Biological Markers 26: 209-215.
57. Hanahan, D., and R.A. Weinberg. 2011. Hallmarks of cancer: The next generation. Cell 144: 646-674.
58. Harizi, H., J.B. Corcuff, and N. Gualde. 2008. Arachidonic-acid-derived eicosanoids: Roles in biology and immunopathology. Trends in Molecular Medicine 14: 461-469.
59. Haro, H., H.C. Crawford, B. Fingleton, K. Shinomiya, D.M. Spengler, and L.M. Matrisian. 2000. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. The Journal of Clinical Investigation 105: 143-150. (Pubitemid 30054353)
60. Harris, R.E., G.A. Alshafie, H. Abou-Issa, and K. Seibert. 2000. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Research 60: 2101-2103. (Pubitemid 30225166)
61. Harris, R.E. 2009. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 17: 55-67.
62. Heffernan-Stroud, L.A., and L.M. Obeid. 2013. Sphingosine kinase 1 in cancer. Advances in Cancer Research 117: 201-235.
63. Heller, R., Q. Chang, G. Ehrlich, S.N. Hsieh, S.M. Schoenwaelder, P.J. Kuhlencordt, K.T. Preissner, E. Hirsch, and R. Wetzker. 2008. Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells. Cardiovascular Research 80: 96-105.
64. Herszényi, L., G. Lakatos, I. Hritz, M.Z. Varga, G. Cierny, and Z. Tulassay. 2012. The role of inflammation and proteinases in tumor progression. Digestive Diseases 30: 249-254.
65. Hojilla, C.V., G.A. Wood, and R. Khokha. 2008. Inflammation and breast cancer: Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer. Breast Cancer Research 10: 205.
66. Hong, G., L.M. Badudhuin, and Y. Xu. 1999. Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells. FEBS Letters 460: 513-518. (Pubitemid 29518430)
67. Honkoop, A.H., J. Wagstaff, and H.M. Pinedo. 1998. Management of stage III breast cancer. Oncology 55: 218-227. (Pubitemid 28154510)
68. Howe, L.R., K. Subbaramaiah, J. Patel, J.L. Masferrer, A. Deora, C. Hudis, H.T. Thaler, W.J. Muller, B. Du, A.M. Brown, and A.J. Dannenberg. 2002. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Research 62: 5405-5407.
69. Howlader, N., A.M. Noone, M. Krapcho, et al. (eds.). 2012. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda: National Cancer Institute.
70. Hrabec, E., J. Naduk, M. Strek, and Z. Hrabec. 2007. Type IV collagenases (MMP-2 and MMP-9) and their substrates - intracellular proteins, hormones, cytokines, chemokines and their receptors. Postepy Biochemii 53: 37-45.
71. Huang, Y.L., W.P. Huang, and H. Lee. 2011. Roles of sphingosine 1-phosphate on tumorigenesis. The World Journal of Biological Chemistry 2: 25-34.
72. Hsieh, H.L., C.C. Sun, C.B. Wu, C.Y. Wu, W.H. Tung, H.H. Wang, and C.M. Yang. 2008. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells. Journal of Cellular Biochemistry 103: 1732-1746.
73. Jemal, A., F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman. 2011. Global cancer statistics. A Cancer Journal for Clinicians 61: 69-90.
74. Jinga, D.C., A. Blidaru, I. Condrea, C. Ardeleanu, C. Dragomir, G. Szegli, M. Stefanescu, and C. Matache. 2006. MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: Correlations with prognostic factors. Journal of Cellular and Molecular Medicine 10: 499-510. (Pubitemid 44872701)
75. Johnson, K.R., K.P. Becker, M.M. Facchinetti, Y.A. Hannun, and L.M. Obeid. 2002. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). Journal of Biological Chemistry 277: 35257-35262.
76. Kawamori, T., W. Osta, K.R. Johnson, B.J. Pettus, J. Bielawski, T. Tanaka, M.J. Wargovich, B.S. Reddy, Y.A. Hannun, L.M. Obeid, and D. Zhou. 2006. Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB Journal 20: 386-388. (Pubitemid 46671180)
77. Kessenbrock, K., V. Plaks, and Z. Werb. 2010. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141: 52-67.
78. Kim, E.S., Y. Cha, M. Ham, J. Jung, S.G. Kim, S. Hwang, R. Kleemann, and A. Moon. 2013. Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression. Oncogene. doi: 10.1038/onc.2013.319.
79. Kim, E.S., J.B. Jeong, S. Kim, K.M. Lee, E. Ko, D.Y. Noh, K.T. Hwang, J.H. Ha, C.H. Lee, S.G. Kim, and A. Moon. 2010. The G12 family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion. Breast Cancer Research and Treatment 124: 49-61.
80. Kim, E.S., J.S. Kim, S.G. Kim, S. Hwang, C.H. Lee, and A. Moon. 2011. Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-Gαq coupling. Journal of Cell Science 1(124): 2220-2230.
81. Kim, I.Y., H.Y. Yong, K.W. Kang, and A. Moon. 2009. Overexpression of ErbB2 induces invasion of MCF10A human breast epithelial cells via MMP-9. Cancer Letters 18(275): 227-233.
82. Kim, M.S., E.J. Lee, H.R. Kim, and A. Moon. 2003. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Research 63: 5454-5461. (Pubitemid 37139864)
83. Kleemann, R., P.P. Gervois, L. Verschuren, B. Staels, H.M. Princen, and T. Kooistra. 2003. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation. Blood 101: 545-551. (Pubitemid 36077576)
84. Kluk, M.J., and T. Hla. 2002. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochimica et Biophysica Acta 1582: 72-80. (Pubitemid 34634113)
85. Kobayashi, N., T. Nishi, T. Hirata, A. Kihara, T. Sano, Y. Igarashi, and A. Yamaguchi. 2006. Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. Journal of Lipid Research 47: 614-621. (Pubitemid 43345602)
86. Kobayashi, N., A. Yamaguchi, and T. Nishi. 2009. Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. Journal of Biological Chemistry 284: 21192-21200.
87. Kundu, J.K., and Y.J. Surh. 2008. Inflammation: Gearing the journey to cancer. Mutation Research 659: 15-30.
88. Laskin, D.L. 2009. Macrophages and inflammatory mediators in chemical toxicity: A battle of forces. Chemistry Research in Toxicology 22: 1376-1385.
89. Lee, H., C.I. Lin, J.J. Liao, Y.W. Lee, H.Y. Yang, C.Y. Lee, H.Y. Hsu, and H.L. Wu. 2004. Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism. American Journal of Physiology Cell Physiology 287: C1657-C1666.
90. Leek, R.D., and A.L. Harris. 2002. Tumor-associated macrophages in breast cancer. Journal of Mammary Gland Biology and Neoplasia 7: 177-189. (Pubitemid 38420774)
91. Leek, R.D., N.C. Hunt, R.J. Landers, C.E. Lewis, J.A. Royds, and A.L. Harris. 2000. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. Journal of Pathology 190: 430-436. (Pubitemid 30163582)
92. Leek, R.D., R. Landers, S.B. Fox, F. Ng, A.L. Harris, and C.E. Lewis. 1998. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. British Journal of Cancer 77: 2246-2251. (Pubitemid 28263948)
93. Leek, R.D., C.E. Lewis, R. Whithouse, M. Greenall, J. Clarke, and A.L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Research 56: 4625-4629. (Pubitemid 26338061)
94. Lewis, C.E., and R. Hughes. 2007. Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: Hypoxia and angiopoietin-2. Breast Cancer Research 9: 209.
95. Lewis, C.E., R. Leek, A.L. Harris, and J.O.D. McGee. 1995. Cytokine regulation of angiogenesis in breast cancer: The role of tumor associated macrophages. Journal of Leukocyte Biology 57: 747-751.
96. Lewis, C.E., and J.W. Pollard. 2006. Distinct role of macrophages in different tumor microenvironments. Cancer Research 66: 605-612. (Pubitemid 43165918)
97. Lin, C.I., C.N. Chen, J.H. Chen, and H. Lee. 2006. Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. Journal of Cellular Biochemistry 99: 1216-1232. (Pubitemid 44673976)
98. Lin, E.Y., and J.W. Pollard. 2007. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Research 67: 5064-5066. (Pubitemid 46997238)
99. Liotta, L.A., and W.G. Stetler-Stevenson. 1991. Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Research 51: 5054s-5059s.
100. Long, J.S., J. Edwards, C. Watson, S. Tovey, K. Mair, R. Schiff, V. Natarajan, N.J. Pyne, and S. Pyne. 2010a. Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor positive breast cancer cells. Molecular and Cellular Biology 30: 3827-3841.
101. Long, J.S., Y. Fujiwara, J. Edwards, C. Tannahill, G. Tigyi, S. Pyne, and N.J. Pyne. 2010b. Sphingosine 1-phosphate 4 uses HER2 (ErbB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells. Journal of Biological Chemistry 285: 35957-35966.
102. Lorusso, G., and C. Rüegg. 2008. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochemistry and Cell Biology 130: 1091-1103.
103. Lu, H., W. Ouyang, and C. Huang. 2006. Inflammation, a key event in cancer development. Molecular Cancer Research 4: 221-233.
104. Lu, J., K.D. Marjon, L.L. Marnell, R. Wang, C. Mold, T.W. Du Clos, and P. Sun. 2011. Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein. Proceedings of the National Academy of Sciences 108: 4974-4979.
105. Lucia, M.S., and K.C. Torkko. 2004. Inflammation as a target for prostate cancer chemoprevention: Pathological and laboratory rationale. Journal of Urology 171: S30-S34.
106. Malla, N., S. Sjoli, J.O. Winberg, E. Hadler-Olsen, and L. Uhlin-Hansen. 2008. Biological and pathobiological functions of gelatinase dimers and complexes. Connective Tissue Research 49: 180-184.
107. Manicone, A.M., and J.K. McGuire. 2008. Matrix metalloproteinases as modulators of inflammation. Seminars in Cell and Developmental Biology 19: 34-41. (Pubitemid 350235986)
108. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature 454: 436-444.
109. Mantovani, A., B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immunology Today 13: 265-270.
110. Mantovani, A., F. Marchesi, C. Porta, A. Sica, and P. Allavena. 2007. Inflammation and cancer: Breast cancer as a prototype. Breast 16: S27-S33.
111. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 25: 677-686. (Pubitemid 39457982)
112. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology 23: 549-555. (Pubitemid 35223554)
113. McArdle, P.A., K. Mir, A.S. Almushatat, A.M. Wallace, M.A. Underwood, and D.C. McMillan. 2006. Systemic inflammatory response, prostate-specific antigen and survival in patients with metastatic prostate cancer. Urologia Internationalist 77: 127-129. (Pubitemid 44195771)
114. McMillan, D.C., K. Canna, and C.S. McArdle. 2003. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. British Journal of Surgery 90: 215-219. (Pubitemid 36237897)
115. McQuibban, G.A., J.H. Gong, J.P. Wong, J.L. Wallace, I. Clark-Lewis, C.M. Overall. 2002. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100: 1160-1167. (Pubitemid 34864266)
116. Miles, D.W., L.C. Happerfield, M.S. Naylor, L.G. Bobrow, R.D. Rubens, and F.R. Balkwill. 1994. Expression of tumour necrosis factor (TNF-α) and its receptors in benign and malignant breast tissue. International Journal of Cancer 56: 777-782. (Pubitemid 24102739)
117. Montero, I., J. Orbe, N. Varo, O. Beloqui, J.I. Monreal, J.A. Rodríguez, J. Díez, P. Libby, and J.A. Páramo. 2006. CRP induces matrix metalloproteinase-1 and -10 in human endothelial cells: Implications for clinical and subclinical atherosclerosis. Journal of the American College of Cardiology 47: 1369-1378.
118. Moon, A., M.S. Kim, T.G. Kim, S.H. Kim, H.E. Kim, Y.Q. Chen, and H.R. Kim. 2000. H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: A role for MMP-2 in the H-rasinduced invasive phenotype. International Journal of Cancer 85: 176-181. (Pubitemid 30023064)
119. Moshage, H.J., H.M. Roelofs, J.F. van Pelt, B.P. Hazenberg, M.A. van Leeuwen, P.C. Limburg, L.A. Aarden, and S.H. Yap. 1988. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochemical and Biophysical Research Communications 155: 112-117.
120. Murphy, G., A. Murthy, and R. Khokha. 2008. Clipping, shedding and RIPping keep immunity on cue. Trends in Immunology 29: 75-82.
121. Nabata, A., M. Kuroki, H. Ueba, S. Hashimoto, T. Umemoto, H. Wada, T. Yasu, M. Saito, S. Momomura, and M. Kawakami. 2008. C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: Implications for the destabilization of atherosclerotic plaque. Atherosclerosis 196: 129-135.
122. Nakopoulou, L., E.G. Panayotopoulou, I. Giannopoulou, P. Alexandrou, S. Katsarou, P. Athanassiadou, and A. Keramopoulos. 2002. Stromelysin-3 protein expression in invasive breast cancer: Relation to proliferation, cell survival and patients' outcome. Modern Pathology 15: 1154-1161. (Pubitemid 35435133)
123. Nava, V.E., J.P. Hobson, S. Murthy, S. Milstien, and S. Spiegel. 2002. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Experimental Cell Research 281: 115-127. (Pubitemid 35373788)
124. Nielsen, B.S., F. Rank, J.M. López, M. Balbin, F. Vizoso, L. Lund, K. Danø, and C. López-Otín. 2001. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Research 61: 7091-7100. (Pubitemid 32946500)
125. Nishi, T., N. Kobayashi, Y. Hisano, A. Kawahara, and A. Yamaguchi. 2013. Molecular and physiological functions of sphingosine 1-phosphate transporters. Biochimica et Biophysica Acta S1388-1981: 00150-00159.
126. Nishikawa, T., K. Hagihara, S. Serada, T. Isobe, A. Matsumura, J. Song, T. Tanaka, I. Kawase, T. Naka, and K. Yoshizaki. 2008. Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression. Journal of Immunology 180: 3492-3501.
127. Nixon, G.F. 2009. Sphingolipids in inflammation: Pathological implications and potential therapeutic targets. British Journal of Pharmacology 158: 982-993.
128. O'Hanlon, D.M., J. Lynch, M. Cormican, and H.F. Given. 2002. The acute phase response in breast carcinoma. Anticancer Research 22: 1289-1293. (Pubitemid 34836188)
129. Olivera, A. 2008. Unraveling the complexities of sphingosine-1-phosphate function: The mast cell model. Prostaglandins and Other Lipid Mediators 86: 1-11.
130. O'Sullivan, C., and C.E. Lewis. 1994. Tumour-associated leucocytes: Friends or foes in breast carcinoma. Journal of Pathology 172: 229-235. (Pubitemid 24151973)
131. Paik, J.H., S. Chae, M.J. Lee, S. Thangada, and T. Hla. 2001. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. Journal of Biological Chemistry 276: 11830-11837.
132. Park, C.C., M.J. Bissell, and M.H. Barcellos-Hoff. 2000. The influence of the microenvironment on the malignant phenotype. Molecular Medicine Today 6: 324-329. (Pubitemid 30619340)
133. Parks, W.C., C.L. Wilson, and Y.S. Lopez-Boado. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Reviews Immunology 4: 617-629. (Pubitemid 39025047)
134. Payne, S.G., S. Milstien, and S. Spiegel. 2002. Sphingosine-1-phosphate: Dual messenger functions. FEBS Letters 531: 54-57. (Pubitemid 35232784)
135. Pchejetski, D., T. Böhler, J. Stebbing, and J. Waxman. 2011. Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer. Nature Reviews Urology 8: 569-678.
136. Pettus, B.J., J. Bielawski, A.M. Porcelli, D.L. Reames, K.R. Johnson, J. Morrow, C.E. Chalfant, L.M. Obeid, and Y.A. Hannun. 2003. The sphingosine kinase 1/sphingosine-1 phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-a. FASEB Journal 17: 1411-1421. (Pubitemid 36939148)
137. Pettus, B.J., C.E. Chalfant, and Y.A. Hannun. 2004. Sphingolipids in inflammation: Roles and implications. Current Molecular Medicine 4: 405-418. (Pubitemid 38787009)
138. Philip, M., D.A. Rowley, and H. Schreiber. 2004. Inflammation as a tumor promoter in cancer induction. Seminars in Cancer Biology 14: 433-439. (Pubitemid 39360991)
139. Pierce, B.L., R. Ballard-Barbash, L. Bernstein, R.N. Baumgartner, M.L. Neuhouser, M.H. Wener, K.B. Baumgartner, F.D. Gilliland, B.E. Sorensen, A. McTiernan, and C.M. Ulrich. 2009. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. Journal of Clinical Oncology 27: 3437-3444.
140. Pollard, J.W. 2008. Macrophages define the invasive microenvironment in breast cancer. Journal of Leukocyte Biology 84: 623-630.
141. Posner, M.C., and N. Wolmark. 1992. Non-invasive breast carcinoma. Breast Cancer Research and Treatment 21: 155-164.
142. Pyne, N.J., and S. Pyne. 2010. Sphingosine 1 phosphate and cancer. Nature Reviews Cancer 10: 489-503.
143. Pyne, S., and N. Pyne. 2000. Sphingosine 1-phosphate signalling in mammalian cells. The Biochemical Journal 349: 385-402. (Pubitemid 30465772)
144. Rahme, E., J. Ghosn, K. Dasgupta, R. Rajan, and M. Hudson. 2005. Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer 5: 159.
145. Ravishankaran, P., and R. Karunanithi. 2011. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients. World Journal of Surgical Oncology 6: 9-18.
146. Rivera, R., and J. Chun. 2008. Biological effects of lysophospholipids. Reviews of Physiology Biochemistry and Pharmacology 160: 25-46.
147. RodrI′guez, D., C.J. Morrison, and C.M. Overall. 2010. Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics. Biochimica et Biophysica Acta 1803: 39-54.
148. Rosen, H., P.J. Gonzalez-Cabrera, M.G. Sanna, and S. Brown. 2009. Sphingosine 1-phosphate receptor signaling. Annual Review of Biochemistry 78: 743-768.
149. Ryu, Y., N. Takuwa, N. Sugimoto, S. Sakurada, S. Usui, H. Okamoto, O. Matsui, and Y. Takuwa. 2002. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circulation Research 90: 325-332. (Pubitemid 34633934)
150. Saad, S., D.J. Gottlieb, K.F. Bradstock, C.M. Overall, and L.J. Bendall. 2002. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Research 62: 283-289. (Pubitemid 34074016)
151. Salgado, R., S. Junius, I. Van Benoy, P. Dam, P. Vermeulen, E. Van Marck, P. Huget, and L.Y. Dirix. 2003. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. International Journal of Cancer 103: 642-646. (Pubitemid 36091468)
152. Sarkar, S., M. Maceyka, N.C. Hait, S.W. Paugh, H. Sankala, S. Milstien, and S. Spiegel. 2005. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Letters 579: 5313-5317. (Pubitemid 41395149)
153. Sbardella, D., G.F. Fasciglione, M. Gioia, C. Ciaccio, G.R. Tundo, S. Marini, and M. Coletta. 2012. Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processes. Molecular Aspects of Medicine 33: 119-208.
154. Schmid, M.C., and J.A. Varner. 2010. Myeloid cells in the tumor microenvironment: Modulation of tumor angiogenesis and tumor inflammation. Journal of Oncology 2010: 201026.
155. Schultz, D.R., and P.I. Arnold. 1990. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Seminars in Arthritis and Rheumatism 20: 129-147.
156. Scorilas, A., A. Karameris, N. Arnogiannaki, A. Ardavanis, P. Bassilopoulos, T. Trangas, and M. Talieri. 2001. Overexpression of matrix-metalloproteinase-9 in human breast cancer: A potential favourable indicator in node-negative patients. British Journal of Cancer 84: 1488-1496. (Pubitemid 32579341)
157. Scott, H.R., D.C. McMillan, L.M. Forrest, D.J. Brown, C.S. McArdle, and R. Milroy. 2002. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. British Journal of Cancer 87: 264-267.
158. Shim, J.Y., H.J. An, Y.H. Lee, S.K. Kim, K.P. Lee, and K.S. Lee. 2003. Overexpression of cyclooxygenase-2 is associated with breast carcinoma and its poor prognostic factors. Modern Pathology 16: 1199-1204. (Pubitemid 38018600)
159. Shin, I., S. Kim, H. Song, H.R. Kim, and A. Moon. 2005. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: Its critical role in invasion and migration of breast epithelial cells. Journal of Biological Chemistry 280: 14675-14683. (Pubitemid 40562814)
160. Sica, A., T. Schioppa, A. Mantovani, and P. Allavena. 2006. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. European Journal of Cancer 42: 717-727.
161. Siehler, S., and D.R. Manning. 2002. Pathways of transduction engaged by sphingosine phosphate through G protein-coupled receptors. Biochimica et Biophysica Acta 1582: 94-99. (Pubitemid 34634116)
162. Silverstein, M.J. 1998. Ductal carcinoma in situ of the breast. BMJ 317: 734-739.
163. Song, H., S.H. Ki, S.G. Kim, and A. Moon. 2006. Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Research 66: 10487-10496. (Pubitemid 44799770)
164. Spiegel, S., and S. Milstien. 2003. Sphingosine-1-phosphate: An enigmatic signaling lipid. Nature Reviews Molecular Cell Biology 4: 397-407.
165. Stetler-Stevenson, W.G. 1999. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. The Journal of Clinical Investigation 103: 1237-1241. (Pubitemid 29218293)
166. Stetler-Stevenson, W.G., and A.E. Yu. 2001. Proteases in invasion: Matrix metalloproteinases. Seminars in Cancer Biology 11: 143-152. (Pubitemid 32423289)
167. Sun, Y., N. Lu, Y. Ling, Y. Gao, Y. Chen, L. Wang, R. Hu, Q. Qi, W. Liu, Y. Yang, Q. You, and Q. Guo. 2009. Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. European Journal of Pharmacology 603: 22-28.
168. Swartz, M.A., N. Iida, E.W. Roberts, S. Sangaletti, M.H. Wong, F.E. Yull, L.M. Coussens, and Y.A. DeClerck. 2012. Tumor microenvironment complexity: Emerging roles in cancer therapy. Cancer Research 72: 2473-2480.
169. Taha, T.A., K.M. Argraves, and L.M. Obeid. 2004. Sphingosine-1-phosphate receptors: Receptor specificity versus functional redundancy. Biochimica et Biophysica Acta 1682: 48-55. (Pubitemid 38670534)
170. Takabe, K., S.W. Paugh, S. Milstien, and S. Spiegel. 2008. "Inside-out" signaling of sphingosine-1-phosphate: Therapeutic targets. Pharmacological Reviews 60: 181-195. (Pubitemid 351962008)
171. Talvensaari-Mattila, A., P. Pääkko, G. Blanco-Sequeiros, and T. Turpeenniemi-Hujanen. 2001. Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy. Breast Cancer Research and Treatment 65: 55-61. (Pubitemid 32163500)
172. Talvensaari-Mattila, A., P. Pääkkö, and T. Turpeenniemi-Hujanen. 2003. Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. British Journal of Cancer 89: 1270-1275. (Pubitemid 37363416)
173. Tan, M., J. Yao, and D. Yu. 1997. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Research 57(6): 1199-1205. (Pubitemid 27138623)
174. Tani, M., T. Sano, M. Ito, and Y. Igarashi. 2005. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. Journal of Lipid Research 46: 2458-2467. (Pubitemid 41532534)
175. Tauseef, M., V. Kini, N. Knezevic, M. Brannan, R. Ramchandaran, H. Fyrst, J. Saba, S.M. Vogel, A.B. Malik, and D. Mehta. 2008. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circulation Research 103: 1164-1172.
176. Tillett, W.S., and T. Francis. 1930. Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. Journal of Experimental Medicine 52: 561-571.
177. Tron, K., D.E. Manolov, C. Röcker, M. Kächele, J. Torzewski, and G.U. Nienhaus. 2008. C-reactive protein specifically binds to Fcgamma receptor type I on a macrophage-like cell line. European Journal of Immunology 38: 1414-1422.
178. Tsung, K., J.P. Dolan, Y.L. Tsung, and J.A. Norton. 2002. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Research 62: 5069-5075. (Pubitemid 34984436)
179. Ulrich, C.M., J. Bigler, and J.D. Potter. 2006. Nonsteroidal anti-inflammatory drugs for cancer prevention: Promise, perils and pharmacogenetics. Nature Reviews Cancer 6: 130-140. (Pubitemid 43361545)
180. Van Brocklyn, J.R., M.J. Lee, R. Menzeleev, A. Olivera, L. Edsall, O. Cuvillier, D.M. Thomas, P.J. Coopman, S. Thangada, C.H. Liu, T. Hla, and S. Spiegel. 1998. Dual actions of sphingosine-1-phosphate: Extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. Journal of Cell Biology 142: 229-240. (Pubitemid 28341153)
181. Van Laere, S.J., G.G. Van den Eynden, I. Van der Auwera, M. Vandenberghe, P. van Dam, E.A. Van Marck, K.L. van Golen, P.B. Vermeulen, and L.Y. Dirix. 2006. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Research and Treatment 95: 243-255.
182. Van Lint, P., and C. Libert. 2007. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. Journal of Leukocyte Biology 82: 1375-1381. (Pubitemid 350276947)
183. van Netten, J.P., B.J. Ashmead, D. Cavers, C. Fletcher, I.G. Thornton, B.L. Antonsen, P. Coy, and M.L. Brigden. 1992. 'Macrophages' and their putative significance in human breast cancer. British Journal of Cancer 66: 220-221.
184. Villaseñor, A., A. Ambs, R. Ballard-Barbash, K.B. Baumgartner, A. McTiernan, C.M. Ulrich, M.L. Neuhouser. 2011. Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: The HEAL study. Breast Cancer Research and Treatment 129: 485-494.
185. Visscher, D.W., M. Höyhtyä, S.K. Ottosen, C.M. Liang, F.H. Sarkar, J.D. Crissman, and R. Fridman. 1994. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. International Journal of Cancer 59: 339-344. (Pubitemid 24331823)
186. Volanakis, J.E. 2001. Human C-reactive protein: Expression, structure, and function. Molecular Immunology 38: 189-197. (Pubitemid 32786776)
187. Wang, D., and R.N. Dubois. 2010. Eicosanoids and cancer. Nature Reviews Cancer 10: 181-193.
188. Wang, D., Z. Zhao, A. Caperell-Grant, G. Yang, S.C. Mok, J. Liu, R.M. Bigsby, and Y. Xu. 2008. S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells. Molecular Cancer Therapeutics 7: 1993-2002.
189. Wang, F., K. Nohara, A. Olivera, E.W. Thompson, and S. Spiegel. 1999a. Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate. Experimental Cell Research 247: 17-28. (Pubitemid 29393958)
190. Wang, F., J.R. Van Brocklyn, J.P. Hobson, S. Movafagh, Z. Zukowska-Grojec, S. Milsteion, and S. Spiegel. 1999b. Sphingosine 1-phosphate stimulates cell migration through a Gi-coupled cell surface receptor: Potential involvement in angiogenesis. Journal of Biological Chemistry 274: 35343-35350. (Pubitemid 129512822)
191. Wang, M.T., K.V. Honn, and D. Nie. 2007. Cyclooxygenases, prostanoids, and tumor progression. Cancer and Metastasis Reviews 26: 525-534. (Pubitemid 350115125)
192. Watson, C., J.S. Long, C. Orange, C.L. Tannahill, E. Mallon, L.M. McGlynn, S. Pyne, N.J. Pyne, and J. Edwards. 2010. High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. American Journal of Pathology 177: 2205-2215.
193. Winberg, J.O., S.O. Kolset, E. Berg, and L. Uhlin-Hansen. 2000. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. Journal of Molecular Biology 304: 669-680. (Pubitemid 32006198)
194. Wong, V.K., H.Z. Malik, Z.Z. Hamady, A. Al-Mukhtar, D. Gomez, K.R. Prasad, G.J. Toogood, and J.P. Lodge. 2007. C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. British Journal of Cancer 96: 222-225. (Pubitemid 46160625)
195. Wu, Z.S., Q. Wu, J.H. Yang, H.Q. Wang, X.D. Ding, F. Yang, and X.C. Xu. 2008. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. International Journal of Cancer 122: 2050-2056. (Pubitemid 351441195)
196. Wu, W.T., C.N. Chen, C.I. Lin, J.H. Chen, and H. Lee. 2005. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology 146: 3387-3400. (Pubitemid 41058111)
197. Xin, C., S. Ren, B. Kleuser, S. Shabahang, W. Eberhardt, H. Radeke, M. Schäfer-Korting, J. Pfeilschifter, and A. Huwiler. 2004. Sphingosine 1-phosphate cross activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses. Journal of Biological Chemistry 279: 35255-35262. (Pubitemid 39100522)
198. Yatomi, Y., F. Ruan, S. Hakomori, and Y. Igarashi. 1995. Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86: 193-202.
199. Yonemura, Y., Y. Endo, T. Takino, K. Sakamoto, E. Bandou, K. Kinoshita, S. Fushida, K. Miwa, K. Sugiyama, and T. Sasaki. 2000. Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancer. Clinical and Experimental Metastasis 18: 321-327. (Pubitemid 32579401)
200. Zhao, C., M.J. Fernandes, M. Turgeon, S. Tancrède, J. Di Battista, P.E. Poubelle, and S.G. Bourgoin. 2008. Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: Impact of TNF-alpha. Journal of Lipid Research 49: 2323-2337.